Health Benefits Industry Veteran Chris Covill Joins Accolade

Health Benefits Industry Veteran Chris Covill Joins Accolade June 05, 2015, 09:44

Accolade, the market-leading consumer health engagement and influence platform for large employers and payers, today announced that Chris Covill, a seasoned health and benefits strategist, has joined the company as executive vice president of Strategic Partnerships.

«Chris is an ideal person to lead our partnership strategy at a time of rapid opportunity and growth for the company," said Accolade Chief Operating Officer Jack Stoddard. «His deep experience and relationships in the health benefits space will help us expand collaborations across the healthcare ecosystem to better serve our clients and customers.»

In this new role, Chris will lead Accolade’s large employer solution strategy, building partnerships with the benefits consultants they trust to shape their benefits design and guide their innovation strategies. He’ll also be responsible for partnering with leading health management and technology companies to integrate innovative tools and point solutions into Accolade’s consumer engagement and influence platform.

Chris joins the company with more than 30 years of experience and P&L responsibility in the employee benefits industry, including nine years with Mercer and its holding company, Marsh & McLennan Cos. He most recently was partner and North America sales leader for Mercer Health & Benefits. During his tenure at Mercer, Chris also served as the national product solutions leader for Health & Benefits, spearheading the U.S. private exchange product strategy for the Mercer Marketplace. Prior to Mercer, Chris was president and chief executive officer of Aflac Benefits Solutions — a subsidiary of Aflac — focused on providing dedicated and specialized services to the nation’s largest brokerage firms.

Chris earned his BA from Ithaca College in New York and resides in Marietta, Ga., with his family.

About Accolade
Accolade is the country’s leading consumer healthcare engagement and influence platform for large self-insured employers and payer organizations. We help consumers navigate the complex world of healthcare and benefits, find the right providers and get the right care the first time. Our fully integrated solution is delivered through a powerful combination of Accolade Health Assistants^® and advanced technology. By addressing some of the biggest problems facing healthcare — low engagement, lack of trust, and consumer knowledge gaps and errors — we’re able to consistently save our customers 5–15 percent per year while delighting the individuals and family members we serve. Headquartered in Plymouth Meeting, Pa., Accolade has been recognized as one of the nation’s 25 most promising companies by Forbes magazine, the fastest-growing private healthcare company by Inc. 500 and a Top Workplace in Philadelphia for five consecutive years. For more information, visit www.accolade.com.

SOURCE Accolade

You may also be interested in

Personalized melanoma vaccines marshal powerful immune response

Personalized melanoma vaccines can be used to marshal a powerful immune response against unique mutations in patients’ tumors, according to early data in a first-in-people clinical trial at Washington University School of Medicine in St. Louis. The tailor-made vaccines, given to three patients with advanced melanoma, appeared to increase the number and diversity of cancer-fighting T cells responding to the tumors. The finding is a boost to cancer immunotherapy, a treatment strategy that unleashes the immune system to seek out and destroy cancer. The research is reported April 2 in Science Express, in a special issue devoted to cancer immunology and immunotherapy.